Business Wire

Milrem Robotics Introduces the New Generation Multi-Purpose Unmanned Ground Vehicle

10.9.2019 09:00:00 EEST | Business Wire | Press release

Share

Milrem Robotics, the leading European manufacturer of unmanned ground vehicles (UGV) and developer of robotic warfare solutions, introduces the fifth generation THeMIS UGV at DSEI 2019 in London designed to assist warfighters and enhance combat effectiveness.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190909005403/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Two THeMIS UGVs delivered to the Royal Netherlands Army were used in a live firing exercise in Austria recently. One was equipped with the deFNder RWS from FN Herstal and the other was used as a transportation platform (Photo: Business Wire)

“In 2015 we exhibited the first THeMIS concept here at DSEI in London. Now, four years later, after extensive testing with industry partners and NATO forces in very demanding environments we are proud to be back here and present a mature and robust product that will greatly enhance warfighting capabilities,” stated Kuldar Väärsi, CEO of Milrem Robotics.

The fifth generation THeMIS incorporates all the knowledge gained during tests held in the US, Europe, the Middle East and deployment in Mali in the French lead Operation Barkhane. The fifth generation THeMIS follows NATO STANAG standards in the vehicle’s architecture, safety, air transportability, power offload and other aspects.

“Our engineers have taken into account the feedback from different armed forces and carried it into the design creating a really robust and reliable tool to support dismounted troops,” Väärsi added.

The THeMIS is a multipurpose tracked vehicle that can be equipped with other warfighting technology such as weapon systems, tethered drones, IED detection devices and much more. It has become the industry standard UGV sought out for various payload integration projects. Together with partners like Kongsberg, FN Herstal, MBDA, ST Engineering etc a dozen different systems have already been integrated. Live firing tests have been conducted with five different weapon systems, including an anti-tank missile launcher.

In addition, Milrem Robotics is working on enhancing the vehicle with autonomous functions including point-to-point navigation, obstacle detection and avoidance. Autonomous functions development is focused on mobility alone, not on weapon systems deployment.

The first fifth generation THeMIS vehicles have already been delivered to the Netherlands and Norway as logistic platforms intended to carry gear and supplies with an option to be integrated with additional warfighting equipment.

The 5th generation THeMIS can be found in the Estonian Pavilion N3-320 and Kongsberg’s stand S6-145 at DSEI 2019.

Please have a look at the THeMIS in action at https://youtu.be/RLU0w8DNo7M.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Gert Hankewitz
Export Director
gert.hankewitz@milrem.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye